The OIC was welcomed as a member of the newly established Canadian RSA Network. We are excited to work with a number of research groups across Canada in order to improve patient safety with regards to implantable medical devices.
Radiostereometric Analysis (RSA) is extremely important for determining the projected survivorship (longevity) of newly introduced orthopaedic implants that have not yet been tested in patients. By using RSA as a diagnostic tool in preliminary clinical trials, surgeons can drastically reduce the number of patients that are exposed to an untested, potentially poor-performing implant, while still obtaining the answers they need.
The RSA program at the Concordia Joint Replacement Group and Concordia Hospital began in 2003 in order monitor implant loosening in patients over time. Today, the OIC manages the RSA program and dedicated digital X-ray suite, and participates in many RSA research initiatives.